Can You Give 1g IM Single Dose for Gonorrhea?
Yes, a single 1g IM dose of ceftriaxone is appropriate and effective for treating uncomplicated gonorrhea, though current U.S. guidelines recommend 500 mg as the standard dose (increasing to 1g for patients ≥150 kg). 1
Current Dosing Recommendations
The FDA-approved labeling explicitly states that for uncomplicated gonococcal infections, a single intramuscular dose of 250 mg is recommended 1. However, this reflects older guidance, and clinical practice has evolved significantly:
- The 2020 CDC update increased the recommended dose to 500 mg IM for uncomplicated urogenital, anorectal, and pharyngeal gonorrhea 2
- European guidelines recommend 1g IM ceftriaxone (in combination with azithromycin 2g orally) as first-line therapy 3
- The FDA label confirms that the usual adult daily dose is 1 to 2 grams for various infections, with no maximum single-dose restriction for gonorrhea beyond general safety limits 1
Evidence Supporting 1g Dosing
The 1g dose has demonstrated excellent efficacy in clinical studies:
- A 2016 Japanese study of 255 men with gonococcal urethritis showed 100% microbiological efficacy with 1g ceftriaxone, with 98.5% of patients testing negative at follow-up 4
- A 2008 study demonstrated 100% eradication of both urogenital and pharyngeal infections, including cefozopran-resistant strains with altered PBP-2, using 1g ceftriaxone 5
- A 2024 hollow fiber infection model study concluded that 1g ceftriaxone should eradicate most internationally spreading ceftriaxone-resistant strains, including those causing oropharyngeal infections 6
Critical Consideration: Pharyngeal Infections
The pharynx is the Achilles' heel of gonorrhea treatment. Most ceftriaxone treatment failures involve pharyngeal infections 3. The 1g dose provides superior pharmacokinetic coverage at this difficult-to-treat anatomical site:
- Pharyngeal gonorrhea requires higher drug concentrations due to poor tissue penetration
- The 1g dose successfully eradicated pharyngeal infections in clinical trials, while lower doses may be inadequate for resistant strains 5, 6
- If pharyngeal infection is suspected or confirmed, the 1g dose is preferable to the standard 500 mg dose
Practical Administration
Reconstitution for 1g IM injection 1:
- Add 3.6 mL diluent to 1g vial for 250 mg/mL concentration
- Add 2.1 mL diluent to 1g vial for 350 mg/mL concentration
- Inject deep into a large muscle mass (gluteal or lateral thigh)
- Aspirate before injection to avoid intravascular administration
Safety Profile
The 1g dose has an excellent safety profile 4, 7:
- Adverse events occur in approximately 3% of patients
- Most common: mild diarrhea (grade 1)
- Rare: urticaria during administration
- No dosage adjustment needed for renal or hepatic impairment 1
When to Use 1g vs 500 mg
Use 1g ceftriaxone IM when:
- Pharyngeal gonorrhea is confirmed or suspected
- Patient weighs ≥150 kg (per current CDC guidance)
- Treating in regions with documented reduced ceftriaxone susceptibility
- Following European treatment guidelines
- Managing potential treatment failure cases
Use 500 mg ceftriaxone IM when:
- Following current U.S. CDC guidelines for uncomplicated urogenital/anorectal gonorrhea
- Patient weighs <150 kg
- No pharyngeal involvement suspected
Critical Pitfall to Avoid
Do not assume chlamydia coverage. Ceftriaxone has no activity against Chlamydia trachomatis 1. If chlamydial coinfection has not been excluded, add doxycycline 100 mg orally twice daily for 7 days 2.